Publications by authors named "Tae In Wi"

Claim this Profile
I
Immune checkpoint silencing using RNAi-incorporated nanoparticles enhances antitumor immunity and therapeutic efficacy compared with antibody-based approaches.
Ji Eun Won, Youngseon Byeon, Tae In Wi, Chan Mi Lee, Ju Hyeong Lee

J Immunother Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NIR irradiation-controlled drug release utilizing injectable hydrogels containing gold-labeled liposomes for the treatment of melanoma cancer.
Ji Eun Won, Tae In Wi, Chan Mi Lee, Ju Hyeong Lee, Tae Heung Kang

Acta Biomater· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian Carcinoma.
Tae In Wi, Ji Eun Won, Chan Mi Lee, Jeong-Won Lee, Tae Heung Kang

Int J Nanomedicine· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective Tumor-Specific Antigen Delivery to Dendritic Cells Using Mannose-Labeled Poly(d, l-lactide-co-glycolide) Nanoparticles for Cancer Immunotherapy.
Tae In Wi, Yeongseon Byeon, Ji Eun Won, Jae Myeong Lee, Tae Heung Kang

J Biomed Nanotechnol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Antitumor Immunity Using a Tumor Cell Lysate-Encapsulated CO-Generating Liposomal Carrier System and Photothermal Irradiation.
Ji Eun Won, Yeongseon Byeon, Tae In Wi, Jae Myeong Lee, Tae Heung Kang

ACS Appl Bio Mater· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
Ga Hee Kim, Ji Eun Won, Yeongseon Byeon, Min Gi Kim, Tae In Wi

Drug Deliv· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.
Yeongseon Byeon, Jeong-Won Lee, Whan Soo Choi, Ji Eun Won, Ga Hee Kim, Tae In Wi

Cancer Res· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis